Download Citation
Article Source:
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
Morris JC,
Tan AR,
Olencki TE,
Shapiro GI,
Dezube BJ,
et al.
(2014)
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma.
PLOS ONE 9(3): e90353.
https://doi.org/10.1371/journal.pone.0090353